米ギリアド・サイエンシズは6月29日、新型コロナ治療薬レムデシビルについて、先進国政府向けの価格を患者1人あたり2340ドルに設定すると発表した。1本当たりは390ドル。標準的治療では5日間で6本投与される。

Did you know BigPharma doesn’t believe in telling you price of their drugs?

In my next story, I asked Roche to tell me how much Cipla is supposed to sell Tociliuzumab for, given the shortage & blackmarket. They refused.

Here’s Gilead on Remdesivir: $2340https://t.co/ZeV5eCfUHM

— Anoo Bhuyan (@AnooBhu) June 29, 2020

Sonra insan haklarindan bahsediyorlar…5 gunluk remdesivire 2340 dolar fatura😒
Gilead Sciences has said it will charge governments $2,340 for a 5-day course of remdesivir, a drug that has been shown to shorten the time it takes Covid-19 patients to recover. FT

— Gözde Kuyumcu (@GozdeKuyumcu) June 29, 2020